Monitoring patients for retained products of conception
Diagnosis of gestational trophoblastic disease (GTD), testicular tumors, ovarian germ cell tumors, teratomas, and, rarely, other human chorionic gonadotropin (hCG)-secreting tumors
Serial measurement of hCG following treatment to:
-Monitor therapeutic response in GTD or in hCG-secreting tumors
-Detect persistent or recurrent GTD or hCG-secreting tumors
1.0 mL Serum from a Red Top Tube in a Plastic Vial
7 days Refrigerated
0.3 mL
Refer to interpretive report
All values > 4 and < 10 will have the following message applied, if the patient is female or no gender is provided: Values less than 10 are considered normal for postmenopausal females. Values from different assay methods may vary. The use of this assay to monitor or to diagnose patients with cancer or any condition unrelated to pregnancy has not been approved by the FDA or the manufacturer of this assay.
Monitoring patients for retained products of conception
Diagnosis of gestational trophoblastic disease (GTD), testicular tumors, ovarian germ cell tumors, teratomas, and, rarely, other human chorionic gonadotropin (hCG)-secreting tumors
Serial measurement of hCG following treatment to:
-Monitor therapeutic response in GTD or in hCG-secreting tumors
-Detect persistent or recurrent GTD or hCG-secreting tumors
3 to 5 days
00910074
84702